Company

NeuroVision Imaging, Inc.

California-based retinal imaging platform using AI to identify signs of Alzheimer's disease, founded in 2010.

About

NeuroVision Imaging, Inc. provides Afina Retinal Imaging, cloud-based AI software that uses retinal images to identify signs of Alzheimer's disease and Cerebral Amyloid Angiopathy, and BrainHealth.net, a telehealth platform for people with cognitive impairments. Founded in 2010 by CEO Steven R. Verdooner and Keith Black, it raised USD 11.2 million in Series C financing in May 2018, led by Wildcat Capital Management, Johnson & Johnson Innovation, SBI Investment, SP Global and Whittier Ventures. The company works with health systems, national testing labs and pharma companies.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in